Business Description
Biolase Inc
NAICS : 339114
SIC : 5047
ISIN : US0909112072
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.41 | |||||
Equity-to-Asset | 0.01 | |||||
Debt-to-Equity | 57.45 | |||||
Debt-to-EBITDA | -1 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -13.34 | |||||
Beneish M-Score | -3.22 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -65.7 | |||||
3-Year EBITDA Growth Rate | 72.4 | |||||
3-Year EPS without NRI Growth Rate | 72.5 | |||||
3-Year FCF Growth Rate | 71.8 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.33 | |||||
9-Day RSI | 49.3 | |||||
14-Day RSI | 48.11 | |||||
6-1 Month Momentum % | -88.67 | |||||
12-1 Month Momentum % | -99.2 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.17 | |||||
Quick Ratio | 0.64 | |||||
Cash Ratio | 0.3 | |||||
Days Inventory | 153.79 | |||||
Days Sales Outstanding | 39.52 | |||||
Days Payable | 72.79 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -343.8 | |||||
Shareholder Yield % | -80.13 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 34.25 | |||||
Operating Margin % | -35.17 | |||||
Net Margin % | -43.56 | |||||
FCF Margin % | -30.9 | |||||
ROE % | -450.44 | |||||
ROA % | -56.03 | |||||
ROIC % | -89.71 | |||||
ROC (Joel Greenblatt) % | -165.05 | |||||
ROCE % | -102.77 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -0.88 | |||||
EV-to-EBITDA | -1.07 | |||||
EV-to-Forward-EBITDA | -4.36 | |||||
EV-to-Revenue | 0.34 | |||||
EV-to-Forward-Revenue | 0.32 | |||||
EV-to-FCF | -1.1 | |||||
Price-to-Median-PS-Value | 0.01 | |||||
Earnings Yield (Greenblatt) % | -113.64 | |||||
FCF Yield % | -284.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Biolase Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 45.11 | ||
EPS (TTM) (€) | -18.208 | ||
Beta | 1.76 | ||
Volatility % | 118.45 | ||
14-Day RSI | 48.11 | ||
14-Day ATR (€) | 0.01065 | ||
20-Day SMA (€) | 0.14001 | ||
12-1 Month Momentum % | -99.2 | ||
52-Week Range (€) | 0.113 - 15.4 | ||
Shares Outstanding (Mil) | 33.26 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Biolase Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Biolase Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Biolase Inc Frequently Asked Questions
What is Biolase Inc(STU:BTH0)'s stock price today?
When is next earnings date of Biolase Inc(STU:BTH0)?
Does Biolase Inc(STU:BTH0) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |